Vaccines for measles, mumps, rubella, and varicella in children.
CONCLUSIONS: Existing evidence on the safety and effectiveness of MMR/MMRV vaccines support their use for mass immunisation. Campaigns aimed at global eradication should assess epidemiological and socioeconomic situations of the countries as well as the capacity to achieve high vaccination coverage. More evidence is needed to assess whether the protective effect of MMR/MMRV could wane with time since immunisation. PMID: 32309885 [PubMed - in process]
Conclusion: We have identified multiple areas of interest in the design and production of educational resources for individuals with SCI. PMID: 32970969 [PubMed - as supplied by publisher]
INTRODUCTION: The Burn Model System (BMS) program of research has been funded since 1993 by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). The overarching aim of this program is to improve outcomes and qual...
Individuals with intellectual disabilities (IDs) are at increased susceptibility to adverse life experiences and trauma sequelae. There is a disparate range of therapeutic interventions for post-traumatic stress disorder (PTSD) and associated symptoms. Thi...
[Abstract unavailable] Language: en...
Publication date: Available online 24 September 2020Source: The Lancet Respiratory MedicineAuthor(s): Christopher E Brightling, Mina Gaga, Hiromasa Inoue, Jing Li, Jorge Maspero, Sally Wenzel, Samopriyo Maitra, David Lawrence, Florian Brockhaus, Thomas Lehmann, Caterina Brindicci, Barbara Knorr, Eugene R Bleecker
Publication date: Available online 24 September 2020Source: The Lancet Respiratory MedicineAuthor(s): Anna Schultze, Alex J Walker, Brian MacKenna, Caroline E Morton, Krishnan Bhaskaran, Jeremy P Brown, Christopher T Rentsch, Elizabeth Williamson, Henry Drysdale, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J Curtis, Amir Mehrkar, David Evans, Peter Inglesby, Jonathan Cockburn, Helen I McDonald, Laurie Tomlinson
Authors: Crowley EL, Nezamololama N, Papp K, Gooderham MJ Abstract INTRODUCTION: Janus kinase (JAK) inhibitors are emerging treatments in dermatology. Also known as JAKinibs, these agents target JAK-signal transducers and activators of transcription (JAK-STAT) pathway for intracellular signaling. Among the various immune-mediated inflammatory skin diseases that the JAK-STAT pathway plays a role in, atopic dermatitis (AD) is an important one. AD has a complex and multifactorial pathophysiology that is not fully understood. Immune dysregulation can result in epidermal barrier disruption and intensify atopic dermatiti...
Publication date: Available online 24 September 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Laura Pazzagli, Lamya Abdi, Helle Kieler, Carolyn E. Cesta
No abstract available
No abstract available
More News: Acute Leukemia | Asthma | Autism | Chickenpox | Children | Clinical Trials | Databases & Libraries | Dermatitis | Dermatology | Diabetes | Diabetes Type 1 | Disability | Eczema | Encephalitis | Endocrinology | Epidemiology | General Medicine | Hay Fever | Inflammatory Bowel Disease | Leukemia | Measles | Measles Vaccine | Men | Meningitis | Meningitis Vaccine | MMR (Measles,Mumps,Rubella) Vaccine | Multiple Sclerosis | Mumps | Mumps Vaccine | Respiratory Medicine | Rubella | Rubella Vaccine | Study | Vaccines